Understanding how the NLRP3 inflammasome is activated
Elucidating the functional mechanism of NLRP3 inflammasome activation
['FUNDING_R01'] · BOSTON CHILDREN'S HOSPITAL · NIH-11041081
This study is looking at a part of your immune system called the NLRP3 inflammasome to understand how it causes inflammation and cell damage, which could help us learn more about diseases like Alzheimer's and other age-related issues, ultimately aiming to find new ways to help patients feel better.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON CHILDREN'S HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11041081 on ClinicalTrials.gov |
What this research studies
This research investigates the NLRP3 inflammasome, a key component of the innate immune system that can trigger inflammation and cell death in response to various stress signals. By examining how NLRP3 is activated, the research aims to uncover its role in diseases such as Alzheimer's and other aging-related disorders. The approach involves studying the molecular interactions and mechanisms that lead to inflammasome activation, which could provide insights into potential therapeutic targets. Patients may benefit from a better understanding of how inflammation contributes to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other aging-related disorders characterized by inflammation.
Not a fit: Patients with non-aging related conditions or those not experiencing significant inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce inflammation and improve outcomes for patients with Alzheimer's and related diseases.
How similar studies have performed: Previous research has shown that targeting inflammasome pathways can be effective in treating inflammatory diseases, suggesting a promising avenue for this investigation.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON CHILDREN'S HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WU, HAO — BOSTON CHILDREN'S HOSPITAL
- Study coordinator: WU, HAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: aging associated disease, aging associated disorders, aging related disease, aging related disorders